Search hospitals > Michigan > Flint
Genesys Hurley Cancer Institute
Claim this profileFlint, Michigan 48503
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
448 reported clinical trials
7 medical researchers
Summary
Genesys Hurley Cancer Institute is a medical facility located in Flint, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Genesys Hurley Cancer Institute is involved with conducting 448 clinical trials across 469 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Tareq Al BaghdadiSaint Joseph Mercy Hospital7 years of reported clinical research
Expert in Cancer
Expert in Tumors
70 reported clinical trials
127 drugs studied
Christopher M. Reynolds, MDSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
45 reported clinical trials
99 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Elie G. DibSaint Joseph Mercy Hospital4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
34 reported clinical trials
94 drugs studied
Clinical Trials running at Genesys Hurley Cancer Institute
Breast Cancer
Cancer
Lung Cancer
Gastric Cancer
Non-Small Cell Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer
Esophageal Adenocarcinoma
Squamous Cell Carcinoma
Multiple Myeloma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Genesys Hurley Cancer Institute?
Genesys Hurley Cancer Institute is a medical facility located in Flint, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Genesys Hurley Cancer Institute is involved with conducting 448 clinical trials across 469 conditions. There are 7 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Genesys Hurley Cancer Institute located?
The Genesys Hurley Cancer Institute is located at 302 Kensington Ave, Flint, MI 48503.
Who should I call to ask about financial aid or insurance network?
For financial assistance, contact the Financial Assistance Discount Program (FADP) at Genesys Hurley Cancer Institute at (810) 262-9260, Option #5, available Monday-Friday from 8am-5pm. For insurance inquiries, reach out to their insurance service specialists at the same number. The general contact number for the institute is 810-762-8226.
What insurance does Genesys Hurley Cancer Institute accept?
The Genesys Hurley Cancer Institute accepts most U.S. insurances. For coverage confirmation or inquiries, contact your insurance carrier or the Hurley Insurance Specialist Team at (810) 262-9096 (Option #3). Note: Some physician specialists may not participate in your health plan, affecting coverage; uninsured patients may qualify for Hurley Medical Center's discount program.
What awards or recognition has Genesys Hurley Cancer Institute received?
Genesys Hurley Cancer Institute, located in Flint, Michigan, is renowned for its exceptional research and care in the field of oncology. It is a key member of the Michigan Cancer Research Consortium (MCRC), which was awarded a $19.3 million grant by the National Cancer Institute in 2019. This grant supports the MCRC's mission to enhance access to advanced cancer treatments for patients across the community.